Entera Bio Ltd.
For the period ended Dec 31, 2025. Filed Mar 27, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 27, 2026
ENTX$3.25+3.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(U.S. dollars in thousands, except share data)
| 2025 | 2024 | |
|---|---|---|
| Assets | ||
| CURRENT ASSETS: | ||
| Cash and cash equivalents | 7,108 | 8,660 |
| Accounts receivable | - | 126 |
| Restricted cash | 7,775 | - |
| Other current assets | 415 | 186 |
| TOTAL CURRENT ASSETS | 15,298 | 8,972 |
| NON-CURRENT ASSETS: | ||
| Property and equipment, net | 134 | 57 |
| Operating lease right-of-use assets | 465 | 275 |
| Restricted deposit | 90 | 80 |
| Funds in respect of employee rights upon retirement | 6 | 6 |
| TOTAL NON-CURRENT ASSETS | 695 | 418 |
| TOTAL ASSETS | 15,993 | 9,390 |
| Liabilities and shareholders' equity | ||
| CURRENT LIABILITIES: | ||
| Accounts payable | 448 | 132 |
| Accrued expenses and other payables | 1,525 | 874 |
| Current maturities of operating lease | 230 | 170 |
| TOTAL CURRENT LIABILITIES | 2,203 | 1,176 |
| NON-CURRENT LIABILITIES: | ||
| Operating lease liabilities | 260 | 102 |
| Other long-term liability | 393 | - |
| Liability for employee rights upon retirement | 36 | 32 |
| TOTAL NON-CURRENT LIABILITIES | 689 | 134 |
| TOTAL LIABILITIES | 2,892 | 1,310 |
| COMMITMENTS AND CONTINGENCIES | ||
| SHAREHOLDERS' EQUITY: | ||
| Ordinary Shares, NIS 0.0000769 par value: Authorized - as of December 31, 2025 and December 31, 2024, 140,010,000 shares; issued and outstanding as of December 31, 2025, and December 31, 2024, 46,178,630 and 38,837,220 shares, respectively | 1 | 1 |
| Additional paid-in capital | 138,425 | 121,965 |
| Accumulated other comprehensive income | 41 | 41 |
| Accumulated deficit | (125,366) | (113,927) |
| TOTAL SHAREHOLDERS' EQUITY | 13,101 | 8,080 |
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | 15,993 | 9,390 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.